Target intelligence / Profile preview

RAD1 pseudogene 1 (RAD1P1)

Target
RAD1P1
Molecular classification
Other (Pseudogene)
01

Overview

RAD1 pseudogene 1 (RAD1P1) is classified as a pseudogene related to the RAD1 gene, which encodes a component of the 9-1-1 DNA checkpoint complex involved in DNA damage response and repair[1][3]. Unlike functional genes, pseudogenes like RAD1P1 are typically noncoding due to disabling mutations and do not produce functional protein products[2][4]. However, pseudogenes may have biological effects at the RNA level, such as acting as competitive endogenous RNAs (ceRNAs) that modulate the activity of microRNAs and influence regulation of their parental or related genes[2][4][10]. RAD1P1 itself is not a known therapeutic target and does not encode a functional protein or recognized drug-binding receptor. Pseudogenes generally do not have direct roles as biomarkers or drug targets, but increasing evidence suggests that some can influence gene networks and might play indirect modulatory roles, including in cancer or other diseases, by interfering with RNA regulatory mechanisms[2][4][6][10]. No drugs or mechanisms of action are known for RAD1P1; it should not be considered a direct target for drug development. RAD1P1 is most accurately classified under "Other (Pseudogene)" and, for most purposes, is not a biologically or pharmacologically actionable target.

Other names
RAD1P1
02

Biological functions

Competing endogenous RNA (ceRNA) activityPossible microRNA regulation
03

Disease associations

Other (Regulatory roles in disease have been described for some pseudogenes, but not specifically for RAD1P1)

Beyond the preview

Go deeper on RAD1 pseudogene 1 (RAD1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAD1 pseudogene 1 (RAD1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call